Abutaily A, Addis B, Roche W
J Clin Pathol. 2002; 55(9):662-8.
PMID: 12194995
PMC: 1769743.
DOI: 10.1136/jcp.55.9.662.
Buley I
J Clin Pathol. 1993; 46(10):881-5.
PMID: 8227400
PMC: 501610.
DOI: 10.1136/jcp.46.10.881.
Anderson T, Holmes E, Kosaka C, Cheng L, Saxton R
J Clin Immunol. 1987; 7(3):254-61.
PMID: 3597716
DOI: 10.1007/BF00915731.
Herbert A
Thorax. 1986; 41(3):176-89.
PMID: 3520935
PMC: 460291.
DOI: 10.1136/thx.41.3.176.
DONNA A, Betta P, Robutti F
J Clin Pathol. 1987; 40(12):1428-31.
PMID: 3323251
PMC: 1141278.
DOI: 10.1136/jcp.40.12.1428.
Immunocytological staining reactions of anti-carcinoembryonic antigen, Ca, and anti-human milk fat globule monoclonal antibodies on benign and malignant exfoliated mesothelial cells.
Ghosh A, Butler E
J Clin Pathol. 1987; 40(12):1424-7.
PMID: 3323250
PMC: 1141277.
DOI: 10.1136/jcp.40.12.1424.
HMFG-2 as a prognostic indicator in superficial bladder cancer.
Conn I, Crocker J, Emtage L, Wallace D
J Clin Pathol. 1988; 41(11):1191-5.
PMID: 3209706
PMC: 1141729.
DOI: 10.1136/jcp.41.11.1191.
New marker for mesothelioma: an immunoperoxidase study.
DONNA A, Betta P, Bellingeri D, Marchesini A
J Clin Pathol. 1986; 39(9):961-8.
PMID: 3093540
PMC: 500194.
DOI: 10.1136/jcp.39.9.961.
Evaluation of impact of immunocytochemical techniques in cytological diagnosis of neoplastic effusions.
Linari A, Bussolati G
J Clin Pathol. 1989; 42(11):1184-9.
PMID: 2685053
PMC: 501979.
DOI: 10.1136/jcp.42.11.1184.
Malignant mesothelioma.
Rudd R
J R Soc Med. 1989; 82(3):126-9.
PMID: 2649672
PMC: 1292032.
DOI: 10.1177/014107688908200302.
Immunohistochemical expression of MAM-3 and MAM-6 antigens in salivary gland tumours.
Yamada K, Tanaka T, Mori M, Tsubura A, Morii S, Tsubone M
Virchows Arch A Pathol Anat Histopathol. 1989; 415(6):509-21.
PMID: 2508309
DOI: 10.1007/BF00718644.
Dysphagia due to mesothelioma infiltrating the oesophagus: palliative treatment.
Lockwood C, Jones H, Foote C, Turner M
J R Soc Med. 1989; 82(3):168.
PMID: 2467986
PMC: 1292046.
DOI: 10.1177/014107688908200318.
Differences in lectin binding of malignant pleural mesothelioma and adenocarcinoma of the lung.
Kawai T, Greenberg S, Truong L, MATTIOLI C, Klima M, TITUS J
Am J Pathol. 1988; 130(2):401-10.
PMID: 2449084
PMC: 1880523.
Immunohistochemistry in the diagnosis of malignant mesothelioma.
Pfaltz M, Odermatt B, Christen B, Ruttner J
Virchows Arch A Pathol Anat Histopathol. 1987; 411(4):387-93.
PMID: 2442887
DOI: 10.1007/BF00713385.
Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies.
Ghosh A, Gatter K, Dunnill M, Mason D
J Clin Pathol. 1987; 40(1):19-25.
PMID: 2434531
PMC: 1140823.
DOI: 10.1136/jcp.40.1.19.
Diagnosing tumours on routine surgical sections by immunohistochemistry: use of cytokeratin, common leucocyte, and other markers.
Poston R, Sidhu Y
J Clin Pathol. 1986; 39(5):514-23.
PMID: 2424934
PMC: 499913.
DOI: 10.1136/jcp.39.5.514.
Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen.
Sheibani K, Battifora H, Burke J
Am J Pathol. 1986; 123(2):212-9.
PMID: 2422942
PMC: 1888323.
The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3).
Szpak C, Johnston W, Roggli V, Kolbeck J, Lottich S, Vollmer R
Am J Pathol. 1986; 122(2):252-60.
PMID: 2418688
PMC: 1888114.
ME1. A monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies.
OHara C, Corson J, Pinkus G, Stahel R
Am J Pathol. 1990; 136(2):421-8.
PMID: 2305835
PMC: 1877403.
The value of anticarcinoembryonic antigen, human milk factor globulin, and antikeratin antibodies in differentiating mesothelioma from lung carcinoma.
Joglekar V, Oliver D, Harris M
Br J Ind Med. 1991; 48(1):34-7.
PMID: 1704251
PMC: 1035309.
DOI: 10.1136/oem.48.1.34.